Gu Limei, Ma Yinuo, Liu Shunji, Zhang Qinchang, Zhang Qiang, Ma Ping, Huang Dongfang, Cheng Haibo, Sun Yang, Ling Tingsheng
Gastrointestinal Endoscopy Center, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincehospital of Chinese Medicine, Nanjing, 210029, China.
State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Chemistry and Biomedicine Innovation Center (Chembic), Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China.
Chin Med. 2025 Mar 5;20(1):31. doi: 10.1186/s13020-025-01082-5.
Colorectal adenoma is a common precancerous lesion with a high risk of malignant transformation. Traditional Chinese medicine and its complex prescriptions have shown promising efficacy in the treatment of adenomas; however, there remains a lack of systematic understanding regarding the compatibility patterns within these prescriptions, as well as an effective model for predicting therapeutic outcomes. In this study, we collected numerous TCM prescriptions and their components, recommended by experts for the treatment of colorectal adenoma, and developed a heterogeneous graph neural network model to predict the compatibility strength and probability among the herbs within these prescriptions. This model delineates the complex relationships among herbs, active compounds, and molecular targets, allowing for a quantification of the interactions and compatibility potential among the herbs. Using this model, we identified high-potential therapeutic prescriptions from clinical prescription records and identified their active components through network pharmacology. Through this approach, we aim to provide a theoretical foundation for the clinical TCM treatment of colorectal adenoma, foster the discovery of new prescriptions to optimize the therapeutic efficacy of TCM, and ultimately advance the field of cancer prevention and treatment based on traditional Chinese medicine.
结直肠腺瘤是一种常见的癌前病变,具有较高的恶变风险。中药及其复方在腺瘤治疗中已显示出有前景的疗效;然而,对于这些方剂中的配伍模式以及预测治疗效果的有效模型仍缺乏系统的认识。在本研究中,我们收集了众多专家推荐用于治疗结直肠腺瘤的中药方剂及其成分,并开发了一种异构图神经网络模型来预测这些方剂中药物之间的配伍强度和概率。该模型描绘了药物、活性成分和分子靶点之间的复杂关系,从而能够对药物之间的相互作用和配伍潜力进行量化。利用该模型,我们从临床处方记录中识别出具有高潜力的治疗方剂,并通过网络药理学确定其活性成分。通过这种方法,我们旨在为结直肠腺瘤的中医临床治疗提供理论基础,促进新方剂的发现以优化中医治疗效果,并最终推动基于中医的癌症防治领域的发展。